Short-acting peptide medication
A three-amino-acid peptide from the same Russian research line as Epithalon, studied around brain cells and oxidative stress.
Form: 5 mg / 10 mg · 3 mL vial · lyophilized
Studied for
- Cognitive-focus conversations
- Longevity protocols
What the research covers
Studied in a rat model of a specific pregnancy complication, measuring offspring behaviour and oxidative stress in neurons. That is a narrow animal model, not human cognition.
- Arutjunyan et al., 2012 — rat model — Int J Clin Exp Med 5:179–185
Questions to ask your provider
- What evidence exists in people?
- Is there anything better established for what I am after?
Educational information only — not medical advice. Eligibility and treatment decisions are made by a licensed medical provider. Results vary and are not guaranteed.
Compounded medications are not FDA-approved or evaluated by FDA for safety, effectiveness, or quality.